Glengary Ventures
VC Fund
Beachwood, United States
Glengary Ventures is a VC fund in Beachwood focused on Health Care and Medical Device. Glengary Ventures succeed when their Client Companies succeed. They invest equity capital in promising early-stage companies, lend value-added expertise and management resources when needed, provide access to markets to hasten growth and counsel so they can avoid pitfalls, reach critical milestones and evolve into the next stage.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Glengary Ventures invests in
Stages Glengary Ventures invests in
Countries Glengary Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Robert A. Lauer
|
|||
Investment Focus
Industry
- Health Care 5 (56%)
- Medical Device 4 (44%)
- Life Science 3 (33%)
- Software 2 (22%)
- Biotechnology 2 (22%)
Stage
- Series A 3 (33%)
- Funding Round 3 (33%)
- Series C 2 (22%)
- Series B 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Robert A. Lauer
Advisroy Partner
|
Advisroy Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
OnShift
|
OnShift delivers cloud-based human capital management software and proactive services to solve everyday workforce challenges in healthcare. Our suite of products for hiring, scheduling and employee engagement drives quality care, lower costs and higher performance by empowering providers to staff consistently and efficiently. Intuitive design,predictive analytics and customer success management are why thousands of post-acute care and senior living organizations rely on OnShift. | $7M / Series C / Feb 03, 2014 | |
SparkBase
|
SparkBase is a gift card and loyalty platform that allows businesses to recognize and reward customers where ever and whenever they engage with their brandThe company's real-time, API-driven loyalty engine uniquely positions SparkBase to integrate with the payment and marketing tools businesses already use to interact with customers,including: payment gateways, POS systems, e-commerce shopping carts, CRMs, email service providers, marketing databases and social media outlets. SparkBase is currently integrated with more than 40 POS systems, multiple payment gateways, and ExactTarget, one of the leading email providers. SparkBase combines best-in-class, proprietary technology with nearly a decade of experience in the loyalty industry. Thousands of businesses in the US and internationally trust SparkBase to power their gift cards and loyalty program and more than 100 resellers choose SparkBase as their preferred loyalty provider. | $5.4M / Series A / Jan 14, 2013 | |
Cardio123
|
CardiOx Corporation develops and offers systems that measure and monitor cardiac output, total circulating blood volume, and endogenous blood ammonia levels. | $4M / Jan 03, 2013 | |
Neuros Medical
|
Neuros Medical is a neuromodulation company, is focused on developing proprietary therapies for the unmet needs of patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgicalpain, and chronic migraine. | $3.5M / Jul 18, 2012 | |
|
Neuros Medical
|
Neuros Medical is a neuromodulation company, is focused on developing proprietary therapies for the unmet needs of patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgicalpain, and chronic migraine. | Series A / Nov 11, 2011 | |
|
Cardio123
|
CardiOx Corporation develops and offers systems that measure and monitor cardiac output, total circulating blood volume, and endogenous blood ammonia levels. | $8M / Series C / Aug 30, 2011 | |
Cleveland HeartLab
|
Cleveland HeartLab, Inc. is a specialty clinical laboratory and disease management company focused on novel biomarker technologies and the creation of proprietary diagnostic tests. | $18.4M / Series B / Aug 22, 2011 | |
EndoSphere
|
Endosphere is a developer of the novel endo-metabolic device category that provides non-invasive endoscopic therapies for gastrointestinal (GI) disorders and metabolic diseases including obesity, non-alcoholic fatty liver disease, type 2 diabetes, and drug delivery. It treats obesity using the body's natural physiology that enables patientsto safely and effectively lose weight without the need for surgery or medications.Endosphere was founded in 2006 and is headquartered in Columbus, Ohio. | $3M / Series A / Jun 01, 2011 | |
|
Cleveland HeartLab
|
Cleveland HeartLab, Inc. is a specialty clinical laboratory and disease management company focused on novel biomarker technologies and the creation of proprietary diagnostic tests. | $3M / Mar 02, 2010 |
Co-Investors
North Coast Ventures
5 deals together
Early Stage Partners
3 deals together
Ohio TechAngels Fund
3 deals together
Lifeline Ventures
2 deals together
Queen City Angels
2 deals together
Reservoir Venture Partners
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Glengary Ventures invest in?
Glengary Ventures invests primarily in Health Care, Medical Device and Life Science startups, most often at Series A and Funding Round stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Glengary Ventures?
Public channels for Glengary Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Glengary Ventures?
The team at Glengary Ventures includes Robert A. Lauer (Advisroy Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
